Oruka Therapeutics, Inc. (ORKA) — Net Asset Quality Index
Oruka Therapeutics, Inc. (ORKA) has a Net Asset Quality Index of 95.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $509.25 Million minus total liabilities of $22.46 Million yields net assets of $486.79 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Oruka Therapeutics, Inc. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Oruka Therapeutics, Inc. Net Asset Quality Index Over Time (2005–2024)
This chart shows how Oruka Therapeutics, Inc.'s Net Asset Quality Index has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the index stands at 95.6%, representing net assets of $486.79 Million against total assets of $509.25 Million USD. See Oruka Therapeutics, Inc. (ORKA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Oruka Therapeutics, Inc. (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for Oruka Therapeutics, Inc. from 2005 to 2024, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Oruka Therapeutics, Inc. worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 96.5% | $382.22 Million | $396.02 Million | $13.80 Million | ▼ -1.3 pp |
| 2023 | 97.8% | $37.02 Million | $37.86 Million | $841.00K | ▲ +1.1 pp |
| 2022 | 96.7% | $41.67 Million | $43.09 Million | $1.41 Million | ▲ +3.8 pp |
| 2021 | 92.9% | $51.04 Million | $54.92 Million | $3.88 Million | ▲ +0.7 pp |
| 2020 | 92.3% | $46.52 Million | $50.43 Million | $3.91 Million | ▲ +3.1 pp |
| 2019 | 89.2% | $7.61 Million | $8.54 Million | $926.00K | ▲ +0.8 pp |
| 2018 | 88.4% | $6.03 Million | $6.83 Million | $793.00K | ▲ +5.3 pp |
| 2017 | 83.1% | $10.28 Million | $12.37 Million | $2.09 Million | ▼ -7.0 pp |
| 2016 | 90.1% | $22.19 Million | $24.63 Million | $2.44 Million | ▼ -6.1 pp |
| 2015 | 96.2% | $38.07 Million | $39.57 Million | $1.50 Million | ▲ +4.8 pp |
| 2014 | 91.4% | $14.74 Million | $16.13 Million | $1.39 Million | ▲ +0.2 pp |
| 2013 | 91.2% | $15.58 Million | $17.08 Million | $1.50 Million | ▲ +0.7 pp |
| 2012 | 90.5% | $2.91 Million | $3.21 Million | $305.00K | ▲ +2.3 pp |
| 2011 | 88.2% | $5.73 Million | $6.50 Million | $770.00K | ▲ +5.1 pp |
| 2010 | 83.0% | $6.77 Million | $8.16 Million | $1.39 Million | ▲ +3.9 pp |
| 2009 | 79.1% | $7.41 Million | $9.37 Million | $1.96 Million | ▲ +127.0 pp |
| 2008 | -48.0% | $-5.31 Million | $11.08 Million | $16.39 Million | ▼ -104.0 pp |
| 2007 | 56.1% | $67.66 Million | $120.68 Million | $53.02 Million | ▲ +18.2 pp |
| 2006 | 37.9% | $69.84 Million | $184.41 Million | $114.56 Million | ▼ -14.7 pp |
| 2005 | 52.5% | $56.76 Million | $108.05 Million | $51.28 Million | — |